Nanoparticles containing constrained phospholipids deliver mRNA to liver immune cells in vivo without targeting ligands is a research paper published in Bioengineering & Translational Medicine (2020). On theSindex it has a DataRank of 0. It has been cited 76 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R01GM132985‐01
National Institutes of Health
Grant: 1UG3TR002855‐01
National Institutes of Health
Grant: R01DE026941‐03
Shurl and Kay Curci Foundation
Grant: Identifying genes that promote nanoparticle delive
NIGMS NIH HHS
Grant: R01 GM132985
NCATS NIH HHS
Grant: UH3 TR002855
NIDCR NIH HHS
Grant: R01 DE026941
NCATS NIH HHS
Grant: UG3 TR002855
National Institutes of Health
Grant: 5R01DE026941-02
Intratumoral generation of F-Ade to ablate low growth fraction HNSCC
National Institutes of Health
Grant: 5UG3TR002855-03
Highly Specific ZFN-Based HSC Gene Editing Therapies Identified By In Vivo Barcode Nanoparticle Screens And Rationally Designed Mrna
National Institutes of Health
Grant: 1R01GM132985-01
Understanding the Relationship LNP Structure, Cholesterol Trafficking, and InVivo Delivery
FWCI
2.68
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Establishment and evaluation of glucose-modified nanocomposite liposomes for the treatment of cerebral malaria
Additional file 1 of Establishment and evaluation of glucose-modified nanocomposite liposomes for the treatment of cerebral malaria